slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,451-3,480
Pages 202
Rows per page 30
Slide function
3,451-3,480 of 6,044
18
argenx SE | Investor Presentation Deck | 26 slidesargenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
20
The chart uses a horizontal bar format to represent clinical trial phases (Preclinical to Commercial) for multiple indications under four main programs.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
07
The slide uses a timeline-based progression (2023 -> Proof of Value -> Platform Innovation) mapped against product generations.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a timeline-based process flow to illustrate the strategic progression.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a three-column layout with icons to represent strategic pillars.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Loop · Why Now1 hit
04
The slide uses a curved arrow timeline with icons representing key events.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
24
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
08
The slide uses a horizontal bar chart integrated into a table to represent clinical trial phases.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
18
The slide uses a process-oriented layout to describe clinical trial progression.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
31
The slide outlines patient enrollment targets and treatment protocols for specific refractory patient populations.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
36
The slide outlines a dose-escalation study (3+3 design) leading to RP2D selection and subsequent expansion cohorts.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
39
The slide uses a process flow diagram to illustrate dose escalation strategies (Accelerated vs Standard vs Priming).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
40
The slide uses a two-column layout to represent 1H and 2H of 2023.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
16
The slide uses a minimalist design with two primary callout boxes representing financial goals.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Financials1 hit
12
The slide uses a Gantt-style chart to show the progress of three different diagnostic tests across four development phases.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
Includes a capital requirement estimate at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a stepped growth diagram to illustrate the phased rollout.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
04
The slide uses a Gantt-style chart to represent drug development progress.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
08
The slide details specific inclusion/exclusion criteria, including age, mutation status, prior therapy, and washout periods.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
17
The slide uses a process flow diagram to illustrate the trial structure.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
09
The slide uses a process-flow style diagram to show how different business levers contribute to the final outcome.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
23
The slide uses a two-part framework: 'Grow Core Initiatives' and 'Expand the Core'.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
25
The slide uses a formulaic approach: Strategy + Execution = Results.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
26
Includes specific financial metrics regarding debt, leverage, and cash availability.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
28
Uses a concentric circle diagram to represent growth phases over time.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
31
The slide uses a visual progression of bars to represent a strategic roadmap.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
05
The slide uses a Gantt-style chart to map product development stages against clinical phases.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style layout to track drug development progress.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
23
Dare Bioscience | Investor Presentation Deck | 26 slidesDare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
25
The slide uses a bulleted list format to outline specific program milestones for five different assets.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit